Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

June 2022 Issue of The Medicine Maker

Join us in a journey across the global south, as we take a look at a selection of open science projects run by the Drugs for Neglected Diseases initiative. From there, look to the future as we ask the experts: can AI reshape pharma forever? Also in the issue, an interview with a Kyiv-based CRO weathering Russian invasion, the story behind a Euro-African vaccine manufacturing initiative, and the strange case of Sanofi’s ASMR foray into Soundcloud…

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Regulation Business Practice

Words With the Fearless Leader

| Angus Stewart | 6 min read

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

Discovery & Development Clinical Trials

A LEAP of Faith

| Angus Stewart | 6 min read

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

Business & Regulation Marketing

The Pills Are Alive…

| Angus Stewart | 3 min read

…with the Sounds of Sanofi. That’s right, a pharma company has opened a SoundCloud account.

Business & Regulation COVID-19

A Tale of Two Continents

| Angus Stewart

African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

Business & Regulation Supply Chain

The Early Bird Gets the…

| Joy Aho

What are the key decisions that need to be made for cell therapy supply chains?

Business & Regulation Advanced Medicine

Champions of Cell and Gene Therapy

| Angus Stewart

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.

Discovery & Development Drug Discovery

The Final Frontier for Regenerative Medicine

| Stephanie Sutton

What will drug development look like aboard a new commercial space station?

Manufacture Biosimilars

Towards Better Biosimilar Access

| Maryam Mahdi | 4 min read

Though in theory, biosimilars should help improve medicines access, what challenges still stand in the way of therapeutic equality and equity?

Manufacture Packaging

Clinical Trials: Getting Smart with Pill Dispensing

| 6 min read

How can smart packaging designs help boost medical adherance?

Business & Regulation Trends & Forecasts

Kyiv: Escape and Return

Ukrainian drug discovery has been disrupted by war. We spoke to leaders of its largest player about the domestic industry’s past, present, and future.

Manufacture Contract Manufacturing Services

Changing People’s Perspectives

| Stephanie Sutton | 6 min read

We sit down with Akhil Ravi, CEO of Aurigene Pharmaceutical Services, to learn about his career and passion for the industry.

Other issues of 2022